AAAAAA

   
Results: 1-9 |
Results: 9
Inflammatory and ulcerative conditions of the gastrointestinal tract: Pathogenesis prevention and treatment - Preface
Authors: Guglietta, A
Citation: A. Guglietta, Inflammatory and ulcerative conditions of the gastrointestinal tract: Pathogenesis prevention and treatment - Preface, CUR PHARM D, 7(1), 2001, pp. NIL_4-NIL_5
Sertaconazole: In-vitro antifungal activity against vaginal and other superficial yeast isolates
Authors: Carrillo-Munoz, AJ Brio, S Quindos, G Palacin, C Guglietta, A Espinel-Ingroff, A
Citation: Aj. Carrillo-munoz et al., Sertaconazole: In-vitro antifungal activity against vaginal and other superficial yeast isolates, J CHEMOTHER, 13(5), 2001, pp. 555-562
In vitro activity of sertaconazole, fluconazole, ketoconazole, fenticonazole, clotrimazole and itraconazole against pathogenic vaginal yeast isolates
Authors: Palacin, C Tarrago, C Agut, J Guglietta, A
Citation: C. Palacin et al., In vitro activity of sertaconazole, fluconazole, ketoconazole, fenticonazole, clotrimazole and itraconazole against pathogenic vaginal yeast isolates, METH FIND E, 23(2), 2001, pp. 61-64
Abaperidone hydrochloride. Antipsychotic, dopamine D-2 antagonist, 5-HT2A antagonist
Authors: Bolos, J Princep, M Guglietta, A
Citation: J. Bolos et al., Abaperidone hydrochloride. Antipsychotic, dopamine D-2 antagonist, 5-HT2A antagonist, DRUG FUTURE, 26(4), 2001, pp. 335-341
The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy
Authors: Epstein, JB Gorsky, M Guglietta, A Le, N Sonis, ST
Citation: Jb. Epstein et al., The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy, CANCER, 89(11), 2000, pp. 2258-2265
Peptide growth factors in gastrointestinal disorder therapeutics
Authors: Guglietta, A Veljaca, M
Citation: A. Guglietta et M. Veljaca, Peptide growth factors in gastrointestinal disorder therapeutics, DRUG DEVELOPMENT, 2000, pp. 89-112
Lack of beneficial effect of COX-2 inhibitors in an experimental model of colitis
Authors: Lesch, CA Kraus, ER Sanchez, B Gilbertsen, R Guglietta, A
Citation: Ca. Lesch et al., Lack of beneficial effect of COX-2 inhibitors in an experimental model of colitis, METH FIND E, 21(2), 1999, pp. 99-104
Synthesis, structure - Activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, andorally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series
Authors: Song, YT Connor, DT Doubleday, R Sorenson, RJ Sercel, AD Unangst, PC Roth, BD Gilbertsen, RB Chan, K Schrier, DJ Guglietta, A Bornemeier, DA Dyer, RD
Citation: Yt. Song et al., Synthesis, structure - Activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, andorally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series, J MED CHEM, 42(7), 1999, pp. 1151-1160
Synthesis, structure - Activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, andorally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazoleseries
Authors: Song, YT Connor, DT Sercel, AD Sorenson, RJ Doubleday, R Unangst, PC Roth, BD Beylin, VG Gilbertsen, RB Chan, K Schrier, DJ Guglietta, A Bornemeier, DA Dyer, RD
Citation: Yt. Song et al., Synthesis, structure - Activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, andorally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazoleseries, J MED CHEM, 42(7), 1999, pp. 1161-1169
Risultati: 1-9 |